With SynergyMed's noninvasive tumor treatment, our furry companions receive effective and precise care leading to a quicker and healthier recovery.
A 6-year-old dog with breast cancer tumor was treated by SynergyMed technology. The dog is healthy and happy.
There are over 12,000,000 yearly new cancer cases for cats and dogs in the US. About 70% of US households own a pet.
Surgical solutions are risky due bleeding complications, infections, wound dehiscence, and dirty margins.
The non-surgical solution of SynergyMed will serve an unmet need for veterinary companion animals and horses with superficial solid tumors.
Our veterinary device utilizes cutting-edge technology, providing a noninvasive, precise, and effective way to treat superficial solid tumors in companion animals, and wildlife animals.
With the use of FDA-approved nanoparticles and specialized electromagnetic applicators, we can ablate and destroy cancerous tumors without harming the surrounding healthy tissue.
Our technology has shown excellent results in clinical studies on dogs where the tumors were diminished with a few days to a week after the treatment. We are excited to continue our mission of providing a safer and more humane way to treat cancer in animals.
To pre-order our product use the contact link below.
The company is performing clinical studies on dogs with very promising results so far.
Join Our Clinical Studies:
If you are an animal research veterinary hospital in the Northeast region of the United States, and would like to join our studies, let us know by contacting us at the link below. Our veterinary device utilizes cutting-edge technology, providing a noninvasive, precise, and effective way to treat superficial solid tumors in companion animals, and wildlife animals.
Copyright © synergymed-ltd all rights reserved.